Latest AI and machine learning research in leukemia for healthcare professionals.
BACKGROUND: The heterogeneous and aggressive nature of diffuse large B-cell lymphoma (DLBCL) present...
The lack of high-throughput, label-free, and intelligent recognition models for assessing cell death...
The role of PET/CT imaging in chronic lymphoproliferative syndromes (CLL) is debated. This study ex...
The investigation and diagnosis of hematologic malignancy using blood cell image analysis are major ...
BACKGROUND/OBJECTIVES: Quality of life (QoL) is negatively affected in people with all-over pain. Wi...
: Flow cytometric detection of minimal residual disease (MRD) in chronic lymphocytic leukemia (CLL) ...
: While early risk stratification in STEMI is essential, the threat of cardiogenic shock (CS) persis...
Data scieQuerynce (DS) methods and artificial intelligence (AI) are critical in today's healthcare s...
Drug co-assemblies have attracted extensive attention due to their advantages of easy preparation, a...
Gold standard for immunohistochemical analyses is the manual assessment by two specialist pathologis...
Inspired by the human visual system, in-sensor computing has emerged as a promising approach to addr...
OBJECTIVES: Idiopathic pulmonary fibrosis (IPF) is a progressive interstitial lung disease. Chest hi...
The analysis of single small extracellular vesicles (sEVs) could distinguish the heterogeneity of sE...
Fruquintinib (FRUZAQLA) is a highly selective tyrosine kinase inhibitor of all three vascular endoth...
Physical activity is a modifiable factor influencing chronic disease risk. Previous studies often re...
The pro-inflammatory responses in THP-1-derived macrophages and human bronchial epithelial cells (HB...
The rapid advancement of generative artificial intelligence has significantly increased the demand f...
Chemotherapy is one of the most successful strategies for treating cancer. Unfortunately, up to 70 %...
BACKGROUND: The early prediction of lymph node positivity (LN+) after neoadjuvant chemotherapy (NAC)...
Acute myeloid leukemia (AML) is a severe hematological malignancy characterized by high recurrence r...
PURPOSE: Cisplatin treats many common tumors but causes permanent and debilitating hearing loss (HL)...